Side-by-side comparison of AI visibility scores, market position, and capabilities
Meta's standalone VR headset line with Quest 3 ($499) and Quest 3S ($299) mixed reality; $40B+ invested in Reality Labs competing with PlayStation VR2 and Apple Vision Pro for the XR platform.
Meta Quest is Meta Platforms' (NASDAQ: META) standalone virtual reality headset line — the Quest 3 (launched October 2023, $499 for 128GB) and Quest 3S (launched October 2024, $299) offering mixed reality (color passthrough that blends virtual content with the real world), inside-out tracking (no external sensors), and access to the Meta Quest Store with 500+ apps spanning gaming, fitness, social VR, and enterprise applications. Meta has invested over $40 billion in Reality Labs (its metaverse/VR/AR division) since 2019, generating approximately $2 billion in annual Quest hardware and software revenue while posting multi-billion-dollar annual operating losses in the division.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.